Topical Treatments:

• Emollients
• Corticosteroids
• Vitamin D analogs
• Calcineurin Inhibitors
• Other Topical Agents

Systemic Treatments:

• Methotrexate
• Oral Retinoids
• Cyclosporine A

Biological Treatments:

• Enbrel (Etanercept)
• Humira (Adalimumab)
• Remicade (Infliximab)
• Stelara (Ustekinumab)

Phototherapy

• PUVA
• UVB
• Excimer Laser & Light

Ustekinumab

Ustekinumab (trade name Stelara) is a human interleukin-12 and -3 antagonist that is approved by the FDA for the treatment of adult patients 18 years and older with moderate-to-severe chronic plaque psoriasis.

It is administered as a subcutaneous injection once a month for 2 months, and subsequently every 12 weeks.

The rapid onset of action and convenient dosing schedule of ustekinumab make it an attractive preference for treatment of severe or rapidly progressive psoriasis.